Form 4: Colgate-Palmolive Director Defers Compensation into Company Stock

Colgate-Palmolive Company Director John P. Bilbrey acquired 264 shares of common stock at $89.91 per share through a deferred compensation plan.

Summary

• John P. Bilbrey, a Director of Colgate-Palmolive Co. (CL), acquired 264 shares of common stock.
• The transaction occurred on July 1, 2025, with a price of $89.91 per share.
• This acquisition was a portion of his annual cash retainer deferred into a stock unit account, pursuant to the Deferred Compensation Plan for Non-Employee Directors.
• Following this transaction, Mr. Bilbrey directly beneficially owns 36,156 shares of common stock.
• Additionally, 4,719 shares are indirectly beneficially owned by a Trust.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director is increasing their stake in the company, aligning interests with shareholders, even if it's part of a routine compensation plan.

Positives

• Director John P. Bilbrey's acquisition of additional shares demonstrates continued alignment of his interests with shareholders.
• The transaction is part of a pre-existing deferred compensation plan, indicating a structured approach to executive remuneration and equity ownership.

Future Outlook

The document does not provide forward-looking statements or guidance beyond the details of the specific transaction.

Industry Context

This Form 4 filing reflects a routine insider transaction, common across all industries, where directors or executives acquire company stock, often as part of compensation plans. It does not provide broader industry trends or competitive analysis.

Related Party Transactions

• Director John P. Bilbrey acquired shares from Colgate-Palmolive Company as part of his deferred compensation plan, which is a standard related-party transaction between an executive and the company.

Stakeholder Impact

• Shareholders: The transaction slightly increases the director's direct ownership, aligning management interests with shareholder value.
• Employees: No direct impact on general employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Key Dates

Keywords

Colgate-Palmolive, CL, Form 4, Insider Transaction, Director Stock Acquisition, Deferred Compensation, Equity Ownership, SEC Filing